-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R0/EW8htCKQuZDyuThJKiRJscwuneyXA8FL8LWVKcB68isqc2vEdwxjv74usIrgF t/2K+oeDGbsC0YQyZ0L3Xw== 0001178913-08-002545.txt : 20080929 0001178913-08-002545.hdr.sgml : 20080929 20080929061543 ACCESSION NUMBER: 0001178913-08-002545 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20080929 FILED AS OF DATE: 20080929 DATE AS OF CHANGE: 20080929 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ellomay Capital Ltd. CENTRAL INDEX KEY: 0000946394 STANDARD INDUSTRIAL CLASSIFICATION: PRINTING TRADES MACHINERY & EQUIPMENT [3555] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26498 FILM NUMBER: 081092421 BUSINESS ADDRESS: STREET 1: ACKERSTEIN TOWERS STREET 2: 11 HAMENOFIM STREET, P.O.BOX 2148 CITY: HERZLIYA STATE: L3 ZIP: 46120 BUSINESS PHONE: 011972-9-971-5613 MAIL ADDRESS: STREET 1: ACKERSTEIN TOWERS STREET 2: 11 HAMENOFIM STREET, P.O.BOX 2148 CITY: HERZLIYA STATE: L3 ZIP: 46120 FORMER COMPANY: FORMER CONFORMED NAME: NUR MACROPRINTERS LTD DATE OF NAME CHANGE: 19980331 FORMER COMPANY: FORMER CONFORMED NAME: NUR ADVANCED TECHNOLOGIES LTD DATE OF NAME CHANGE: 19950607 6-K 1 zk85866.htm 6-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2008
Commission File Number: 000-26498

Ellomay Capital Ltd.
(Translation of registrant’s name into English)

Ackerstein Towers, 11 Hamenofim St., Herzliya 46120, Israel
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes o No x

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-___________



THE EXHIBITS OF THIS FORM 6-K ARE HEREBY INCORPORATED BY REFERENCE INTO THE REGISTRANT’S REGISTRATION STATEMENTS ON FORM F-3 (NOS. 333-144171, 333-115826, 333-114428, 333-47842 AND 333-92493) AND FORM S-8 (NOS. 333-102288 AND 333-92491), AND TO BE A PART THEREOF FROM THE DATE ON WHICH THIS REPORT IS SUBMITTED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED.

This Report on Form 6-K of Ellomay Capital Ltd. consists of the following documents, which are attached hereto and incorporated by reference herein:

Exhibit 99.1. Unaudited Financial Statements of Ellomay Capital Ltd. for the six months ended June 30, 2008 and the notes thereto.

Exhibit 99.2. Management's Discussion and Analysis of Results of Operations and Financial Condition for the six months ended June 30, 2008 and 2007

2



Signatures

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Ellomay Capital Ltd.


By: /s/ Yosef Zylberberg
——————————————
Yosef Zylberberg
Interim Chief Executive Officer
and Chief Financial Officer

Dated: September 28, 2008

3



EX-99 2 exhibit_99-1.htm 6-K

Exhibit 99.1

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

INTERIM CONSOLIDATED FINANCIAL STATEMENTS

AS OF JUNE 30, 2008

IN U. S. DOLLARS

INDEX

 

 

 

 

 

Page

 

 


 

 

 

Interim Consolidated Balance Sheets

 

F-2

 

 

 

Interim Consolidated Statements of Operations

 

F-3

 

 

 

Interim Statements of Changes in Shareholders’ Equity

 

F-4

 

 

 

Interim Consolidated Statements of Cash Flows

 

F-5 - F-6

 

 

 

Notes to Interim Consolidated Financial Statements

 

F-7 - F-15


F-1



 

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

 

INTERIM CONSOLIDATED BALANCE SHEETS


U.S. dollars in thousands (except per share data)


 

 

 

 

 

 

 

 

 

 

June 30,
2008

 

December 31,
2007

 

 

 


 


 

 

 

Unaudited

 

Audited

 

 

 


 


 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

78,370

 

$

4,302

 

Restricted cash

 

 

 

 

146

 

Trade receivables (net of allowance for doubtful accounts of $ 4,851 at December 31, 2007)

 

 

 

 

15,670

 

Other accounts receivable and prepaid expenses

 

 

3,243

 

 

4,425

 

Assets held for sale

 

 

1,294

 

 

 

Inventories

 

 

 

 

20,091

 

 

 



 



 

 

 

 

 

 

 

 

 

Total current assets

 

 

82,907

 

 

44,634

 

 

 



 



 

 

 

 

 

 

 

 

 

LONG-TERM ASSETS:

 

 

 

 

 

 

 

Severance pay fund

 

 

 

 

1,275

 

Other assets

 

 

41

 

 

474

 

 

 



 



 

 

 

 

 

 

 

 

 

Total long-term assets

 

 

41

 

 

1,749

 

 

 



 



 

 

 

 

 

 

 

 

 

PROPERTY AND EQUIPMENT, NET

 

 

 

 

5,944

 

 

 



 



 

 

 

 

 

 

 

 

 

Total assets

 

$

82,948

 

$

52,327

 

 

 



 



 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

Short-term bank credit and loans

 

$

 

$

13,962

 

Liability held for sale

 

 

942

 

 

 

Current maturities of long-term loans

 

 

 

 

649

 

Trade payables

 

 

112

 

 

21,388

 

Deferred revenues

 

 

 

 

2,434

 

Employees and related benefits

 

 

2,963

 

 

3,690

 

Accrued expenses and other liabilities

 

 

4,376

 

 

7,483

 

 

 



 



 

 

 

 

 

 

 

 

 

Total current liabilities

 

 

8,393

 

 

49,606

 

 

 



 



 

 

 

 

 

 

 

 

 

LONG-TERM LIABILITIES:

 

 

 

 

 

 

 

Long-term loans, net of current maturities

 

 

 

 

19,835

 

Accrued severance pay

 

 

262

 

 

1,637

 

Other long-term liabilities

 

 

4,723

 

 

3,428

 

 

 



 



 

 

 

 

 

 

 

 

 

Total long-term liabilities

 

 

4,985

 

 

24,900

 

 

 



 



 

 

 

 

 

 

 

 

 

COMMITMENTS AND CONTINGENT LIABILITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SHAREHOLDERS’ EQUITY (DEFICIENCY):

 

 

 

 

 

 

 

Share capital -

 

 

 

 

 

 

 

Ordinary shares of NIS 1 par value:

 

 

 

 

 

 

 

Authorized: 170,000,000 at June 30, 2008 and December 31, 2007; Issued and outstanding: 72,720,505 and 72,710,505 shares at June 30, 2008 and December 31, 2007, respectively

 

 

16,525

 

 

16,522

 

Additional paid-in capital

 

 

72,065

 

 

66,328

 

Accumulated other comprehensive income

 

 

 

 

127

 

Accumulated deficit

 

 

(19,020

)

 

(105,156

)

 

 



 



 

 

 

 

 

 

 

 

 

Total shareholders’ equity (deficiency)

 

 

69,570

 

 

(22,179

)

 

 



 



 

 

 

 

 

 

 

 

 

Total liabilities and shareholders’ equity

 

$

82,948

 

$

52,327

 

 

 



 



 

The accompanying notes are an integral part of the interim consolidated financial statements.

F-2



 

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

 

INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS


U.S. dollars in thousands (except per share data)


 

 

 

 

 

 

 

 

 

 

Six months ended June 30,

 

 

 


 

 

 

2008

 

2007

 

 

 


 


 

 

 

Unaudited

 

 

 


 

 

 

 

 

 

 

 

 

Revenues:

 

 

 

 

 

 

 

Products

 

$

10,568

 

$

35,786

 

Services

 

 

842

 

 

2,622

 

 

 



 



 

 

 

 

 

 

 

 

 

Total revenues

 

 

11,410

 

 

38,408

 

 

 



 



 

 

 

 

 

 

 

 

 

Cost of revenues:

 

 

 

 

 

 

 

Products (a)

 

 

7,632

 

 

19,647

 

Inventory write-off

 

 

494

 

 

1,169

 

 

 



 



 

 

 

 

8,126

 

 

20,816

 

 

 

 

 

 

 

 

 

Services

 

 

2,872

 

 

3,498

 

 

 



 



 

 

 

 

 

 

 

 

 

Total cost of revenues

 

 

10,998

 

 

24,314

 

 

 



 



 

 

 

 

 

 

 

 

 

Gross profit

 

 

412

 

 

14,094

 

 

 



 



 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

Research and development

 

 

1,942

 

 

3,514

 

Selling and marketing

 

 

3,080

 

 

6,321

 

General and administrative

 

 

8,091

 

 

5,621

 

Amortization of other intangible assets

 

 

 

 

42

 

 

 



 



 

 

 

 

 

 

 

 

 

Total operating expenses

 

 

13,113

 

 

15,498

 

 

 



 



 

 

 

 

 

 

 

 

 

Operating loss

 

 

(12,701

)

 

(1,404

)

Gain on sale of Company’s business, net

 

 

93,785

 

 

 

Financial income, net

 

 

6,347

 

 

11

 

 

 



 



 

 

 

 

 

 

 

 

 

Income (loss) before taxes on income

 

 

87,431

 

 

(1,393

)

Taxes on income

 

 

1,295

 

 

371

 

 

 



 



 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

86,136

 

$

(1,764

)

 

 



 



 

 

 

 

 

 

 

 

 

Net income per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic:

 

$

1.184

 

$

*)

 

 



 



 

 

 

 

 

 

 

 

 

Diluted:

 

$

0.982

 

$

*)

 

 



 



 


 

 

*)

Less than 0.01.

 

 

(a)

Includes rent expenses charged by a related party totaling $186 and $62 for the 6 month periods ended June 30, 2007 and 2008, respectively.

The accompanying notes are an integral part of the interim consolidated financial statements.

F-3



 

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

 

INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY


U.S. dollars in thousands (except share data)


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of
Ordinary
Shares
outstanding

 

Share
capital

 

Additional
paid-in
capital

 

Accumulated
other
comprehensive
income (loss)

 

Accumulated
deficit

 

Total
comprehensive
income (loss)

 

Total
shareholders’
equity
(deficiency)

 

 

 


 


 


 


 


 


 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of January 1, 2007

 

 

60,523,886

 

 

13,635

 

 

61,956

 

 

(475

)

 

(96,119

)

 

 

 

(21,003

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of shares and warrants, net

 

 

11,734,950

 

 

2,774

 

 

3,303

 

 

 

 

 

 

 

 

6,077

 

Stock - based compensation

 

 

 

 

 

 

1,003

 

 

 

 

 

 

 

 

1,003

 

Exercise of employee stock options

 

 

451,669

 

 

113

 

 

66

 

 

 

 

 

 

 

 

179

 

Cumulative effect adjustment upon adoption of FIN 48

 

 

 

 

 

 

 

 

 

 

(2,617

)

 

 

 

(2,617

)

Comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

 

 

 

 

 

 

 

 

(6,420

)

$

(6,420

)

 

(6,420

)

Foreign currency translation adjustments

 

 

 

 

 

 

 

 

602

 

 

 

 

602

 

 

602

 

 

 



 



 



 



 



 



 



 

Total comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

(5,818

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2007

 

 

72,710,505

 

$

16,522

 

$

66,328

 

$

127

 

$

(105,156

)

 

 

$

(22,179

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock - based compensation

 

 

 

 

 

 

2,187

 

 

 

 

 

 

 

 

2,187

 

Exercise of employee stock options

 

 

10,000

 

 

3

 

 

1

 

 

 

 

 

 

 

 

4

 

Repurchase of options

 

 

 

 

 

 

(1,451

)

 

 

 

 

 

 

 

(1,451

)

Cancellation of a Subordinated note to related parties

 

 

 

 

 

 

5,000

 

 

 

 

 

 

 

 

 

5,000

 

Comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income

 

 

 

 

 

 

 

 

 

 

86,136

 

$

86,136

 

 

86,136

 

Realization of Foreign Currency translation

 

 

 

 

 

 

 

 

(127

)

 

 

 

(127

)

 

(127

)

 

 



 



 



 



 



 



 



 

Total comprehensive Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

86,009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of June 30, 2008

 

 

72,720,505

 

$

16,525

 

$

72,065

 

$

 

$

(19,020

)

 

 

 

$

69,570

 

 

 



 



 



 



 



 

 

 

 



 

The accompanying notes are an integral part of the consolidated financial statements.

F-4



 

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

 

INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS


U.S. dollars in thousands


 

 

 

 

 

 

 

 

 

 

Six months ended June 30,

 

 

 


 

 

 

2008

 

2007

 

 

 


 


 

 

 

Unaudited

 

 

 


 

 

 

 

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

86,136

 

$

(1,764

)

Adjustments to reconcile net income (loss) to net cash used in operating activities:

 

 

 

 

 

 

 

Gain from sale of Company’s business

 

 

(93,785

)

 

 

Depreciation and amortization

 

 

256

 

 

1,005

 

Amortization of other intangible assets

 

 

 

 

42

 

Currency fluctuation of long-term debt

 

 

133

 

 

42

 

Accrued severance pay, net

 

 

98

 

 

(86

)

Stock-based compensation

 

 

3,797

 

 

539

 

Foreign currency translation loss (gain) on inter-company balances with foreign subsidiaries

 

 

109

 

 

(234

)

Amortization of accrued interest on restructured debt

 

 

(7,335

)

 

 

Decrease in trade receivables, net

 

 

4,812

 

 

9

 

Increase in other accounts receivable and prepaid expenses

 

 

(1,338

)

 

(225

)

Increase in inventories

 

 

(2,571

)

 

(262

)

Increase (decrease) in other long-term liability

 

 

1,295

 

 

(280

)

Decrease (increase) in other assets

 

 

27

 

 

(81

)

Increase (decrease) in trade payables

 

 

2,267

 

 

(185

)

Increase in accrued expenses and other liabilities

 

 

661

 

 

946

 

Increase (decrease) in deferred revenues

 

 

718

 

 

(652

)

 

 



 



 

 

 

 

 

 

 

 

 

Net cash used in operating activities

 

 

(4,720

)

 

(1,186

)

 

 



 



 

 

 

 

 

 

 

 

 

Cash flows used in investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property and equipment

 

 

(148

)

 

(592

)

Proceeds from restricted cash

 

 

146

 

 

39

 

Proceeds from sale of the Company’s business, net (2)

 

 

100,732

 

 

 

 

 



 



 

 

 

 

 

 

 

 

 

Net cash provided by (used in) investing activities

 

 

100,730

 

 

(553

)

 

 



 



 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from issuance of shares, net

 

 

 

 

6,095

 

Proceeds from exercise of options, net

 

 

4

 

 

9

 

Short-term bank credit and short-term loans, net

 

 

(8,959

)

 

(285

)

Payment of long-term loans, including interest on restructured debt

 

 

(12,344

)

 

(790

)

 

 



 



 

 

 

 

 

 

 

 

 

Net cash provided by (used in) financing activities

 

 

(21,299

)

 

5,029

 

 

 



 



 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash

 

 

(643

)

 

(98

)

 

 



 



 

 

 

 

 

 

 

 

 

Increase in cash and cash equivalents

 

 

74,068

 

 

3,192

 

Cash and cash equivalents at the beginning of the period

 

 

4,302

 

 

4,868

 

 

 



 



 

 

 

 

 

 

 

 

 

Cash and cash equivalents at the end of the period

 

$

78,370

 

$

8,060

 

 

 



 



 

The accompanying notes are an integral part of the interim consolidated financial statements.

F-5



 

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

 

INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS


U.S. dollars in thousands


 

 

 

 

 

 

 

 

 

 

 

 

Six months ended June 30,

 

 

 

 


 

 

 

 

2008

 

2007

 

 

 

 


 


 

 

 

Unaudited

 

 

 

 


 

 

 

 

 

 

(1)

Supplemental disclosure of cash flows activities:

 

 

 

 

 

 

 

 

Cash paid during the year for:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest

 

$

527

 

$

607

 

 

 

 



 



 

 

 

 

 

 

 

 

 

 

(2)

See Note 1

 

 

 

 

 

 

 

The accompanying notes are an integral part of the interim consolidated financial statements.

F-6



 

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands (except share and per share data)


 

 

NOTE 1:-

GENERAL


 

 

 

 

a.

Ellomay Capital Ltd. (“the Company”) (formerly: NUR Macroprinters Ltd.), an Israeli company, is a shell company whose current plan of operations is to identify and evaluate suitable business opportunities and strategic alternatives, including through the acquisition of all or part of an existing business, pursuing business combinations or otherwise. Until February 29, 2008, the Company and its subsidiaries (collectively, “the Group”) developed, manufactured, sold and provided services of digital printing systems for on-demand, short-run, wide format and super-wide format printing as well as related consumable products.

 

 

 

 

 

Until February 29, 2008, the Company operated through wholly-owned subsidiaries for sales, support services and marketing of the Company’s products in their country or region of domicile. Such entities include NUR Europe S.A. (“NUR Europe”) in Belgium, NUR America, Inc. (“NUR America”) in the U.S., NUR Asia Pacific Limited (“NUR Asia Pacific”) in Hong Kong and NUR Japan Ltd. (“NUR Japan”) in Japan.

 

 

 

 

b.

On December 9, 2007, the Company entered into an Asset Purchase Agreement (“the Agreement”) with Hewlett-Packard Company (“HP”) for the sale of its business to HP (the “HP Transaction”). The Agreement contemplated the sale of substantially all of the assets and liabilities relating to the business with the exception of specific assets and liabilities as defined in the Agreement. In connection with the Agreement, HP also agreed to acquire three of the Company’s subsidiaries, NUR Europe S.A., NUR Japan Ltd and NUR Do Brazil Ltda., a company organized pursuant to the laws of Brazil. In addition to the transfer of the assets, liabilities and aforementioned subsidiaries, one of the conditions to the consummation of the HP Transaction was the transfer of approximately 80% of the Company’s employees to HP and HP’s subsidiaries. The HP Transaction was completed and all included assets, liabilities and employees were transferred from the Company and its subsidiaries to HP and several of its subsidiaries on February 29, 2008 (“Closing Date”).

 

 

 

 

 

As of February 29, 2008, the carrying value of assets and liabilities assumed by HP was as follows:


 

 

 

 

 

 

 

 

 

 

 

 

February 29,
2008

 

 

 


 

 

 

 

 

Cash

 

$

2,883

 

Trade receivables

 

 

11,207

 

Other accounts receivable and prepaid expenses

 

 

2,569

 

Inventories

 

 

22,454

 

Severance pay fund

 

 

1,073

 

Other assets

 

 

406

 

Property, plant and Equipment, net

 

 

5,115

 

Realization of foreign currency translation

 

 

127

 

 

 



 

 

 

 

 

 

Total assets

 

 

45,834

 

 

 



 

 

 

 

 

 

Trade payables

 

 

23,589

 

Other accounts payable and accrued expenses

 

 

7,421

 

Advances from customers

 

 

1,684

 

Accrued severance pay

 

 

1,270

 

 

 



 

 

 

 

 

 

Total liabilities

 

 

33,964

 

 

 



 

 

 

 

 

 

Net assets sold

 

$

11,870

 

 

 



 

F-7



 

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands (except share and per share data)


 

 

NOTE 1:-

GENERAL (Cont.)


 

 

 

The base purchase price pursuant to the agreement was $117,500. The purchase price was subject to upward or downward adjustment based on the net debt (bank debt less cash balances) of the Company and subsidiaries that were not purchased by HP as of the Closing Date. The adjustment on February 29, 2008 was approximately $4,000, for a total consideration under the Agreement of $121,500. Of the total consideration, $103,900 was transferred to the Company on the Closing Date, $1,600 was withheld by HP until final calculation of the net debt at closing, $1,500 was withheld by HP until the assignment to the Company of NUR Europe’s obligations with respect to its capital lease and Government grants and the remaining $14,500 was deposited into an escrow account to secure the indemnity obligations of the Company and its remaining subsidiaries. The escrow funds, net of amounts distributed to HP in satisfaction of indemnity obligations, are to be distributed to the Company in two installments: $9,500 is to be distributed eighteen months after closing and $5,000 is to be distributed twenty-four months after closing. It is too early to determine the probability of receiving such withheld funds from HP and therefore, the $14,500 deposited in the escrow account and the $1,500 withheld with respect to Nur Europe’s obligations, were not recognized as part of the Gain on sale of Company’s business. Those amounts (or any parts of them) will be recorded once their receipt becomes probable.

 

 

 

Assets and liabilities excluded from the Agreement included, but were not limited to: cash balances held by the Company and subsidiaries that were not purchased by HP, short and long term bank credit and loans, all costs incurred in respect to the HP Transaction including severance liabilities, rights and obligations in respect to employees not transferred to HP; rights and obligations related to outstanding litigations, claims and disputes; intercompany balances, all tax benefits and obligations with the exception of such benefits and obligations relating to continuing operations from the Closing Date, assets and obligations in respect of certain government-supported research and development projects and obligations due to or from shareholders.

 

 

 

As part of the agreement, the Company agreed to change its corporate name. The Company’s name was changed to Ellomay Capital Ltd. in April 2008. In addition, the Company agreed not to solicit any former employees who were transferred to HP or to engage in any business engaged directly in the same business as conducted by the Company at closing, both for a period of three years following the closing date.

 

 

 

Following the Transaction with HP, the company decided to sell the building previously used by its European Subsidiary and the capital lease related to it. The Company believes that the building and the capital lease will be sold no later then the end of 2008. On June 30, 2008 the Company determined that the plan of sale criteria in FASB Statement No.144 “Accounting for the Impairment or Disposal of Long Lived Assets” has been met.

 

 

 

In connection with the HP Transaction, the Board of Directors approved the acceleration of the vesting of all outstanding employee stock options following the Closing Date and the repurchase, subject to the fulfillment of regulatory requirements, of the then outstanding employee stock options to purchase approximately 9.9 million Ordinary shares of the Company. The aggregate consideration for such employee stock options, was approximately $ 3,800. Of the total, $ 3,100 was accrued at June 30, 2008 and was paid in July 2008 and an additional payment, up to the aggregate amount, will be calculated after all HP Transaction related issues and other financial aspects of the Company are known and verified and will be paid following the release to the Company of the funds deposited in escrow. In 2008, upon closing of the HP Transaction, the acceleration resulted in full recognition of the remaining unrecognized compensation costs of $ 2,187 and, as a result of the repurchase, an additional compensation cost of $1,610 representing the excess of the purchase price over the fair value of the options at closing. In the six months ended June 30, 2008 a total of 10,000 and 25,467 options, respectively, were exercised and canceled. As of September 15, 2008 there are 143,334 issued and outstanding options that were granted to the Company’s directors and 43,412,756 issued and outstanding warrants.

F-8



 

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands (except share and per share data)


 

 

NOTE 1:-

GENERAL (Cont.)


 

 

 

In connection with the HP Transaction, the Board also approved the payment of transaction bonuses to certain employees in the aggregate amount of approximately $ 700 and established that, subject to the aforementioned determination and verification of all transaction related issues and other financial aspects of the Company, additional bonuses may be paid to certain employees, based on criteria, amounts and percentages pre-determined by the Board. The Company recorded the liability for transaction bonuses in 2008, as of the HP Transaction Closing Date.

 

 

 

As a result of the HP Transaction and the cessation of virtually all operations, a majority of the Company’s employees that have not transferred to HP, including the majority of the Company’s senior management, have been terminated by the Company. In connection with such terminations, the Company recorded severance-related expenses in the approximate amount of $2,800 as of the HP Transaction Closing Date.

 

 

 

Upon consummation of the HP Transaction, in March 2008 the Company repaid short-term debt to its lender banks in the amount of $9,800. In April 2008, it fully repaid outstanding long-term debt to its lenders in the amount of $12,100. In May 2008, a $5,000 subordinated note due to a related party was cancelled effective as of March 30, 2008. In connection with the cancellation of the subordinated note, the Company recognized a capital contribution of $5,000. Upon full repayment of the loans recognized the remaining balance of accrued interest on restructured debt as financial income of approximately $7,335.

 

 

 

Following the consummation of the HP Transaction, the Company’s primary asset is cash deposited in short term deposits and therefore, the sole source of income is interest that such deposits earn

 

 

 

On March 31, 2008 the principal shareholders, the Fortissimo entities, completed the sale of all of the shares and a majority of the warrants held by them to Kanir Joint Investments (2005) L.P., which was also previously a controlling shareholder of the Company and S. Nechama Investments (2008) Ltd., which became a controlling shareholder of the Company as a result of the acquisition of our securities from the Fortissimo entities and from several other shareholders.

F-9



 

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands (except share and per share data)


 

 

NOTE 2:-

SIGNIFICANT ACCOUNTING POLICIES


 

 

 

 

The consolidated financial statements have been prepared according to United States generally accepted accounting principles (“U.S GAAP”), as follows:

 

 

 

 

a.

Unaudited Interim Financial Information

 

 

 

 

 

The accompanying consolidated balance sheet as of June 30, 2008, the consolidated statements of operations for the six months ended June 2007 and 2008, and the consolidated statements of cash flows for the six months ended June 30, 2007 and 2008 are unaudited. These unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. In the opinion of management, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of our consolidated financial position as of June 30, 2008, our consolidated results of operations for the six months ended June 30, 2007 and 2008 and our consolidated cash flows for the six months ended June 30, 2007 and 2008.

 

 

 

 

 

The balance sheet at December 31, 2007 has been derived from the audited consolidated financial statements at that date but does not include all of information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

 

 

 

 

 

These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes for the year ended December 31, 2007 included in our Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (“SEC”) on June 30, 2008. Results for six months ended June 30, 2008 are not necessarily indicative of results that may be expected for the year ending December 31, 2008. Unless otherwise noted, all references to “dollars” or “$” are to United States dollars.

 

 

 

 

b.

Use of estimates:

 

 

 

 

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

 

 

 

 

c.

Principles of consolidation:

 

 

 

 

 

The consolidated financial statements include the accounts of the Company and its wholly- owned subsidiaries. Intercompany transactions and balances, including profit from intercompany sales not yet realized outside the Group, have been eliminated upon consolidation.

F-10



 

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands (except share and per share data)


 

 

NOTE 2:-

SIGNIFICANT ACCOUNTING POLICIES (Cont.)


 

 

 

 

d.

Recently issued accounting pronouncements:

 

 

 

 

 

In May 2008, the Financial Accounting Standards Board issued SFAS No. 162, “The Hierarchy of Generally Accepted Accounting Principles” (“SFAS 162”). SFAS 162 identifies the sources of accounting principles and the framework for selecting the principles used in the preparation of financial statements of nongovernmental entities that are presented in conformity with U.S. generally accepted accounting principles. This statement shall be effective 60 days following the SEC’s approval of the Public Company Accounting Oversight Board’s amendments to AU Section 411, “The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles.” We do not expect the adoption of SFAS 162 to have a material impact on our consolidated financial statements.


 

 

NOTE 3:-

CONTINGENT LIABILITIES


 

 

 

 

a.

Charges and guarantees:

 

 

 

 

 

As of June 30, 2008, the Company obtained bank guarantees in the total amount of $438 in favor of lessors.

 

 

 

 

b.

Royalty commitments:

 

 

 

 

 

During the period 1998-2003, the Company’s European subsidiary received research and development grants totaling € 2,435 ($3,839 at June 30, 2008) from the local authorities in Belgium. Under the terms of the grants, the Company’s European subsidiary has an obligation to pay royalties at the higher of a certain minimum annual amount or at a rate of 4% of the sales derived from the applicable products developed within the framework of such research and development projects, up to an amount equal to the research and development grants received in connection with such products, linked to the Euro. The commencement of the royalty payments to the local authorities in Belgium is contingent upon the Company’s European subsidiary generating sales from products developed under these grants. The grants are not repayable in the event that the Company’s European subsidiary decides to cease the research and development activities, or the exploitation of the products developed under these grants and all know-how and results of the research and development are transferred to the local authorities. In the event that the Company’s European subsidiary decides to cease exploitation of the products developed under these grants, a notification thereof should be given to the local authorities in Belgium.

 

 

 

 

 

The Company’s European subsidiary ceased the research and development activities and the exploitation of certain products for which grants were received. The Company did not submit notification to the local authorities and, instead, continued to pay royalties with a total of € 659 ($1039 at June 30, 2008) remitted through 2005. As of June 30, 2008 and December 31, 2007, the aggregate amount of grants received from the Belgium authorities, which had not yet been repaid amounted to $2,800 and $2,613, respectively (€‎ 1,776 as of June 30, 2008 and December 31, 2007).

F-11



 

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands (except share and per share data)


 

 

NOTE 3:-

CONTINGENT LIABILITIES (Cont.)


 

 

 

 

 

 

In respect to 2006 and 2007, the European subsidiary received notice from the Belgian authorities requesting the annual minimum royalty payments of $285 and $368, respectively. The European subsidiary did not pay the amounts requested as it believes that the royalty payment for 2006 and 2007 should have been only $184 and $250, respectively and that it has overpaid its royalty obligations for prior years. During discussions held with the Belgian authorities in February 2008, the authorities confirmed the Company’s position with respect to the amounts owed for 2006 and 2007. It was also agreed that the Company’s European subsidiary will submit a proposal to the authorities with respect to the overall open balance as described above.

 

 

 

 

 

 

The Company’s European subsidiary offered the Belgian authorities a settlement proposal by which the authorities will waive the repayment of a portion of the grants and, in return, the Company will pay back the sum of $ 615 as full and final settlement. At this stage, the Company is waiting for an official response to its proposal. An accrual of this amount was recorded.

 

 

 

 

 

c.

Legal proceedings:

 

 

 

 

 

 

1.

In January 2008, a former distributor of a subsidiary filed a lawsuit against the subsidiary claiming his distribution agreement was terminated in violation of its terms and seeking damages in the amount of $AUD 5,562 Thousand ($4.9 million). The subsidiary filed a statement of defense denying the claims and a filed counterclaim against the former distributor for non-payment and other damages in the amount of $882. The parties are negotiating a settlement agreement by which the subsidiary Company will pay $175. A provision of $175 and both parties will waive all claims was recorded with respect to this settlement.

 

 

 

 

 

 

2.

During 2003, a former supplier filed a lawsuit against a subsidiary, in the amount of ‎€‎ 943 thousand ($1,487) in connection with a disputed supply agreement. In February 2006, the court determined that the subsidiary is to pay the supplier an aggregate amount of ‎€‎ 1,246 thousand ($1,964) representing penalties and accrued interest. The subsidiary filed an appeal, which was rejected by the court of appeals. During 2007, the Company reached an agreement with the supplier to pay the amount due plus interest on the principal amount over a period of 40 months. Following the consummation of the HP Transaction a second settlement agreement was reached by which the full amount was paid in a lump sum during August 2008.

 

 

 

 

 

 

3.

During 2001, a client filed a lawsuit against a subsidiary in the amount of $450 alleging bad quality of products and damages. The subsidiary filed a counter claim of $216 in respect of unpaid invoices. In October 2007, the court ruled that the client is not entitled for any damages and the subsidiary should credit the client for the unpaid balance. The client was ordered to return the product to the Company’s subsidiary. The ruling was deemed final in April 2008 when the official time for appeal passed.

 

 

 

 

 

 

4.

During 2002, an end-user filed a lawsuit in China against a subsidiary alleging bad quality of products. The court ruled that the subsidiary should reimburse the client with the amount of $186. Following an appeal filed by the subsidiary, the court ruled in September 2003 in favor of the end-user. The subsidiary is in the process of liquidation and has no assets; therefore the plaintiff has no remedy against the subsidiary. The customer may elect to start new proceedings against another subsidiary operating in Hong Kong. However, to date, the customer has not filed any claim in Hong Kong. Based on management’s estimation and the opinion of its legal counsel, it is less than likely that the second subsidiary will be required to pay the amount ruled against the subsidiary in China. Therefore, no provision was recorded with respect to this claim.

F-12



 

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands (except share and per share data)


 

 

NOTE 3:-

CONTINGENT LIABILITIES (Cont.)


 

 

 

 

5.

During 2002, a client filed a lawsuit in China against a subsidiary seeking reimbursement in the amount of $400 alleging bad quality of products. In July 2005, the court ruled that the subsidiary is to reimburse the client an amount of $286. The subsidiary no longer operates in China and under current law the ruling in China is not enforceable in Hong Kong. The subsidiary notified the customer in March 2006 that it intends to vigorously defend its claims if submitted to court in Hong Kong. To date, the customer has not filed any claim in Hong Kong. Based on management’s estimation and the opinion of its legal counsel, it is less than likely that the subsidiary will be required to pay the amount ruled against it in China. Therefore, no provision was recorded with respect to this claim.

 

 

 

 

6.

In September 2003, the Company filed a lawsuit against a former distributor of the Company, for the collection of unpaid invoices in the amount of $420. In February 2004, the former distributor filed a statement of defense denying the Company’s claims and it also filed a counter-claim for alleged damages caused to it by the Company in the amount of $210. Based on the opinion of its legal counsel, management believes that the counter-claim that was filed by the former distributor is without merit and that a loss is not probable. Therefore, a provision was not recorded with respect to this claim.

 

 

 

 

7.

In December 2003, a client of a subsidiary filed a lawsuit alleging that a machine purchased by it failed to perform. The customer is seeking reimbursement of the purchase price paid by it in the amount of $290. Based on management’s estimation and the opinion of its legal counsel, a provision of $145 was recorded with respect to this claim.

 

 

 

 

8.

In May 2007, a former managing director of a subsidiary filed a lawsuit against the Company and two of its subsidiaries claiming his resignation was for just cause due to demotion and therefore should be deemed as a termination of his employment by the subsidiary. The Company denies all the claims made by the former employee. Based on management estimation and the opinion of its legal counsel, no provision was recorded with respect to this claim.

 

 

 

 

9.

In February 2007, a claim was filed against the Company and one of its former officers by a person claiming to have been an agent of the Company in West Africa for commissions on sales of printers. The claim is for NIS 3,000 ($895). The Company filed a statement of defense denying all claims, both with respect to the causes of action and with respect to the factual allegations in the claim. Based on management’s estimation and the opinion of its legal counsel, no provision was recorded with respect to this claim.

 

 

 

 

10.

From time to time, the Company is party to other various legal proceedings, claims and litigation that arise in the normal course of business. It is the opinion of management that the ultimate outcome of these matters will not have a material adverse effect on the Company’s financial position, results of operations or cash flows.

F-13



 

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands (except share and per share data)


 

 

NOTE 4:-

INCOME TAXES


 

 

 

As of June 30, 2008, the total amount of unrecognized tax benefits was $4,723, which, if recognized, would affect the effective tax rates in future periods. Included in that amount are accrued interest and penalties in respect to uncertain tax positions of $761 at June 30, 2008, of which $93 for interest and penalties expenses were recorded during 2008. A reconciliation of the beginning and ending amounts of unrecognized tax benefits as of June 30, 2008 was as follows:


 

 

 

 

 

Balance as of January 1, 2008

 

$

3,428

 

Current year tax positions

 

 

434

 

Increases related to prior years tax positions

 

 

861

 

 

 



 

 

 

 

 

 

Balance as of June 30, 2008

 

$

4,723

 

 

 



 


 

 

NOTE 5: -

BASIC AND DILUTED NET INCOME (LOSS) PER SHARE


 

 

 

Basic net earning/loss per share is computed based on the weighted average number of Ordinary shares outstanding during each period. Diluted net earning per share is computed based on the weighted average number of Ordinary shares outstanding during each period plus dilutive potential Ordinary shares considered outstanding during the period, in accordance with SFAS No. 128, “Earnings Per Share”.

 

 

 

The following table sets forth the computation of basic and diluted net earning per share of common stock:


 

 

 

 

 

 

 

 

 

 

Six months ended June 30,

 

 

 


 

 

 

2008

 

2007

 

 

 


 


 

 

 

Unaudited

 

 

 


 

 

 

 

 

 

 

Numerator

 

 

 

 

 

 

 

Net income (Loss), numerator for basic and diluted per share

 

 

86,136

 

 

(1,764

)

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

Weighted average number of share of common stock

 

 

72,720,010

 

 

65,509,000

 

 

 



 



 

 

 

 

 

 

 

 

 

Effect of dilutive securities:

 

 

 

 

 

 

 

Employee stock options and warrants

 

 

15,002,073

 

 

 

 

 



 



 

 

 

 

 

 

 

 

 

Denominator for diluted net earning per share – weighted average assuming exercise of options

 

 

87,722,083

 

 

65,509,000

 

 

 



 



 

The Total weighted average number of shares related to the outstanding options and warrants excluded from the calculation of diluted net earning per share, as they would have been anti-dilutive for all periods presented, was 14,459,893 and 10,505,608 for the six months ended June 30, 2007 and 2008, respectively,

F-14



 

ELLOMAY CAPITAL LTD. AND ITS SUBSIDIARIES

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands (except share and per share data)


 

 

NOTE 6:-

GEOGRAPHIC INFORMATION


 

 

 

 

a.

Summary information about geographic areas:

 

 

 

 

 

The Company managed its business on the basis of one reportable segment. Refer to Note 1a for a description of the Company’s business. The following data is presented in accordance with SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information”. Total revenues are attributed to geographical areas based on location of end customers.

 

 

 

 

 

The following table presents total revenues for the six months period ended June 30, 2008 and 2007 and long lived assets as of December 31, 2007 and for June 30, 2008:


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30, 2008

 

June 30, 2007

 

December 31, 2007

 

 

 


 


 


 

 

 

Total
revenues

 

Long-lived
assets

 

Total
revenues

 

Long-lived
assets

 

 

 


 


 


 


 

 

 

Unaudited

 

Unaudited

 

Audited

 

 

 


 


 


 

 

 

 

 

 

 

 

 

Asia

 

$

664

 

$

 

$

3,692

 

$

327

 

Europe and Middle East

 

 

7,589

 

 

 

 

21,725

 

 

5,398

 

America

 

 

3,157

 

 

 

 

12,991

 

 

219

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

11,410

 

$

 

$

38,408

 

$

5,944

 

 

 



 



 



 



 


 

 

 

 

b.

Product lines:

 

 

 

 

 

Total revenues from external customers distributed on the basis of the Company’s product lines are as follows:


 

 

 

 

 

 

 

 

 

 

Six months ended June 30,

 

 

 


 

 

 

2008

 

2007

 

 

 


 


 

 

 

Unaudited

 

 

 


 

 

 

 

 

Printers and spare parts

 

$

6,607

 

$

23,364

 

Ink

 

 

3,961

 

 

12,422

 

Services

 

 

842

 

 

2,622

 

 

 



 



 

 

 

 

 

 

 

 

 

 

 

$

11,410

 

$

38,408

 

 

 



 



 

F-15



EX-99 3 exhibit_99-2.htm 6-K

Exhibit 99.2

Management’s Discussion and Analysis of Results of Operations and Financial Condition for the six months ended June 30, 2008 and 2007

          Our discussion and analysis of our financial condition and results of operation are based upon our consolidated financial statements, which have been prepared in accordance with United States generally accepted accounting principles. Our operating and financial review and prospects should be read in conjunction with our unaudited interim consolidated financial statements for the period ended June 30, 2008 and in conjunction with our consolidated financial statements and the related notes and other financial information included in our Annual Report on Form 20-F for the year ended December 31, 2007, filed with the Securities and Exchange Commission, or SEC, on June 30, 2008. Certain statements in this discussion are forward-looking statements.

Overview

          On February 29, 2008 the sale of our wide-format printing business to Hewlett-Packard Company, or HP, and several of its subsidiaries, or the HP Transaction, was consummated. The total consideration paid pursuant to the Asset Purchase Agreement between HP and us, dated December 9, 2007, was $121.5 million (taking into account the purchase price adjustment on that date of closing which was approximately $4 million). At closing, $14.5 million of the purchase price was retained in an indemnity escrow account, approximately $1.6 million was withheld until final calculation of our net debt position at closing and $1.5 million was withheld until the assignment of NUR Europe’s obligations with respect to its capital lease and Government grants to us, resulting in the receipt of $103.9 million by us at closing.

          Following the consummation of the HP Transaction, in March 2008 we repaid our short-term debt to our lender banks, Bank Hapoalim B.M., Bank Leumi Le-Israel B.M. and Israel Discount Bank Ltd., or the Lender Banks, in the amount of $9.8 million and, in early April 2008, we fully repaid our long-term debt to the Lender Banks in the amount of $12.1 million. In August 2008 we received from HP an additional amount of $1.5 million after the final calculation of our net debt position at closing. In addition, in July 2008, we purchased a majority of the outstanding employee stock options from our current and former employees for the aggregate amount of $3.1 million. The employee stock options that were not purchased by us terminated based on their terms and therefore, as of September 15, 2008, we have no outstanding employee stock options (we still have 143,334 options granted to Directors of the company). In connection with the HP transaction we also paid our employees transaction bonuses in the amount of $0.7 million and severance related expenses of $2.8 million. For a more detailed description of our undertakings to our former and current employees in connection with the HP Transaction and the scope of our indemnity obligations to HP, please see the descriptions in our Annual Report on Form 20-F filed with the SEC on June 30, 2008.

          Our current plan of operation is to identify and evaluate suitable business opportunities and strategic alternatives, including through the acquisition of all or part of an existing business, pursuing business combinations or otherwise. Following the closing of the HP Transaction, we have ceased conducting any operating activity and substantially all of our assets consist of cash, cash equivalents and short term bank deposits. We now only conduct activities relating to our efforts to identify business opportunities and strategic alternatives, activities relating to the investment of our funds and activities relating to ensuring the smooth transition of the business acquired by HP as part of the HP Transaction.

2



          Following the consummation of the HP Transaction, our primary asset is cash deposited in short term deposits and therefore, our sole source of income is interest that such deposits earn. As the HP Transaction was consummated on February 29, 2008, our financial results for the six months ended June 30, 2008 include revenues from our wide-format printing business that were generated up to the closing of the HP Transaction. During the six months ended June 30, 2007, we generated revenues primarily from our wide-format printing business that included the sale of our printers and of ink products, spare parts and related services.

          Therefore, the data presented in our interim consolidated financial statements and in our discussion below are not indicative of our future operating results or financial position.

Results of Operations

          The following table sets forth our selected consolidated statements of income for each six month period ended June 30, 2007 and 2008 expressed as a percentage of total revenues. Totals may not add up due to rounding.

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 30,

 

 

 


 

 

 

2008
(unaudited)

 

2007
(unaudited)

 

 

 


 


 

 

 

 

 

 

 

Revenues:

 

 

 

 

 

 

 

Products

 

92.6

%

 

93.2

%

 

Service

 

7.4

 

 

6.8

 

 

Total revenues

 

100

 

 

100

 

 

 

Cost of revenues:

 

 

 

 

 

 

 

Products

 

66.9

 

 

51.2

 

 

Inventory Write-off

 

4.3

 

 

3.0

 

 

 

 

71.2

 

 

54.2

 

 

 

Services

 

25.2

 

 

9.1

 

 

 

 

 

 

 

 

 

 

Total cost of revenues

 

96.4

 

 

63.3

 

 

 

 

 

 

 

 

 

 

Gross profit

 

3.6

 

 

36.7

 

 

 

 

 

 

 

 

 

 

Research and development, net

 

17.0

 

 

9.1

 

 

Selling and marketing

 

27.0

 

 

16.5

 

 

General and administrative expenses

 

70.9

 

 

14.6

 

 

Amortization of other intangible assets

 

 

 

0.1

 

 

Operating loss

 

(111.3

)

 

(3.6

)

 

Gain on sale of company business

 

821.9

 

 

 

 

Financial income, net

 

55.6

 

 

0.0

 

 

Taxes on income

 

(11.3

)

 

(0.9

)

 

Net income (loss)

 

754.9

 

 

(4.5

)

 

3



          The above table presents our financial data together with our subsidiaries NUR America, NUR Europe (which was sold to HP), NUR Asia Pacific, NUR DO Brazil (which was sold to HP), NUR Japan (which was sold to HP), NUR Italy, NUR UK, NUR Hungary Trading and Software Licensing Limited Liability Company and Encre Consumables B.V until February 29, 2008.

Six Months Ended June 30, 2008 Compared with Six Months Ended June 30, 2007

          Revenues. Revenues from product sales and services were approximately $11.4 million in the six months ended June 30, 2008, compared to approximately $38.4 million in the six months ended June 30, 2007.

          The decrease in revenues of $27 million was primarily due to the sale of our business to HP and the cessation of our wide-format printing business at the end of February 2008.

          Revenues-products. Revenues from sales of products were approximately $10.6 million (or 92.6% or total revenues) in the six months ended June 30, 2008, compared to approximately $35.8 million (or 93.2% of total revenues) in the six months ended June 30, 2007.

          The decrease in revenues from products of approximately $25.2 million was mainly attributable to the sale of our business to HP and the cessation of our wide-format printing business at the end of February 2008.

          Revenues-services. Revenues from services rendered were approximately $0.8 million (or 7.4% of total revenues) in the six months ended June 30, 2008, compared to approximately $2.6 million (or 6.8% of total revenues) in the six months ended June 30, 2007.

          The decrease in revenues from services of approximately $1.8 million was mainly attributable to the sale of our business to HP and the cessation of our wide-format printing business at the end of February 2008.

          Cost of revenues. The cost of revenues was approximately $10.9 million (or 96.4% of total revenues) in the six months ended June 30, 2008, compared to approximately $24.3 million (or 63.3% of total revenues) in the six months ended June 30, 2007.

          The decrease in the cost of revenue of approximately $13.4 million was mainly attributed to the sale of our business to HP and the cessation of our wide-format printing business at the end of February 2008. As for the increase in the cost percentage compared with the six month ended June 30, 2007, please see our discussion under “Gross Profit” below.

          Cost of revenues-products. Total cost of revenues-products was approximately $8.1 million (or 71.2% of total revenues) in the six months ended June 30, 2008, compared to approximately $20.8 million (or 54.2% of total revenues) in the six months ended June 30, 2007. The decrease in the cost of revenues-products of approximately $12.7 million was mainly attributable to the sale of our business to HP and the cessation of our wide-format printing business at the end of February 2008.

4



          Cost of revenues-services. Cost of revenues-services was approximately $2.9 million (or 25.2% of total revenues) in the six months ended June 30, 2008, compared to approximately $3.5 million (or 9.1% of total revenues) in the six months ended June 30, 2007. The decrease in the cost of revenues-services was mainly attributable to the sale of our business to HP and the cessation of our wide-format printing business at the end of February 2008 offset by compensation expenses attributable to the above mentioned sale.

          Gross Profit. Gross Profit was approximately $0.4 million in the six months ended June 30, 2008, compared to approximately $14.1 million in the six months ended June 30, 2007. The gross profit as a percentage of revenues was 3.6% in the six months ended June 30, 2008, compared to 36.7% in the six months ended June 30, 2007. The reduction in the gross margin is mainly attributable to the fact that only two months of activity are reflected in the report for 2008. Based on our experience in the years prior to the consummation of the HP Transaction, a large portion of our revenue was generated during the third month of each quarter, while the expenses were more evenly spread throughout the quarter. Accordingly, as we only operated our business during the first two month of 2008, a higher percentage of expenses and a lower gross margin compared with a full quarter (or six months) of activity are reflected. Employee compensation costs related to the HP Transaction also reduced the gross margin.

          Expenses. Net research and development costs were approximately $1.9 million in the six months ended June 30, 2008 compared to approximately $3.5 million in the six months ended June 30, 2007. The decrease in research and development costs was mainly attributable to the sale of our business to HP and the cessation of our wide-format printing business at the end of February 2008.

          Selling and marketing expenses were approximately $3.1 million in the six months ended June 30, 2008, compared to approximately $6.3 million in the six months ended June 30, 2007. The decrease in sales and marketing expenses was mainly attributable to the sale of our business to HP and the cessation of our wide-format printing business at the end of February 2008.

          General and administrative expenses were approximately $8.1 million for the six months ended June 30, 2008, compared to approximately $5.6 million for the six months ended June 30, 2007. The increase in general and administrative expenses was mainly attributable to expenses related to the sale of our printing business, especially to compensation costs to our employees.

          Amortization of other intangible assets was $0 million for the six months ended June 30, 2008, compared to $0.04 million for the six months ended June 30, 2007.

          Financial income increased to approximately $6.3 million in the six months ended June 30, 2008, compared to approximately $0.01 million in the six months ended June 30, 2007. This increase was primarily due to the amortization of the deferred interest following the full repayment of our loans in accordance with the provisions of SFAS No. 15 “Accounting by Debtors and Creditors for Troubled Debt Restructuring.”

5



          Taxes. Taxes on income were approximately $1.3 million in the six months ended June 30, 2008, compared to taxes on income of approximately $0.3 million in the six months ended June 30, 2007, with the increase due to the changes made with respect to our unrecognized tax benefits in accordance with the provisions of FIN 48 “Accounting for Uncertainty in Income Taxes – an interpretation of FASB Statement No 109”.

Certain Critical Accounting Policies and Estimates

          Our discussion and analysis of our financial condition and results of operations are based on our interim consolidated financial statements, which have been prepared in accordance with United States generally accepted accounting principles. While all the accounting policies impact the financial statements, certain policies may be viewed to be critical. These policies are most important for the fair portrayal of our financial condition and results of operations and are those that require our management to make difficult, subjective and complex judgments, estimates and assumptions, based upon information available at the time that they are made, historical experience and various other factors that are believed to be reasonable under the circumstances. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements, as well as the reported amounts of revenues and expenses during the periods presented. Actual results could differ from those estimates.

          The critical accounting policies described in Item 5 in our Annual Report on Form 20-F, filed with the SEC on June 30, 2008, are those that require management’s more significant judgments and estimates used in the preparation of our consolidated financial statements and which were, during the period prior to the sale of our business to HP as described above, the most critical to aid in fully understanding and evaluating our reported financial results. As of February 29, 2008 most of those accounting policies are no longer relevant to our financial statements and therefore material changes to such policies subsequent to such date, if any, are not relevant either.

Liquidity and Capital Resources

          We have incurred operating losses during the last five years. Following the consummation of the HP Transaction and the payment of some related liabilities (including repayment of our short and long-term debt), as of September 15, 2008, we hold approximately $75.6 million in cash and cash equivalents. Our current plan of operation is to identify and evaluate suitable business opportunities and strategic alternatives, including through the acquisition of all or part of an existing business, pursuing business combinations or otherwise. Although we now hold the consideration received from HP in connection with the sale of our business, we may need additional funds if we seek to acquire certain new businesses and operations. If we are unable to raise funds through public or private financing of debt or equity, we will be unable to fund certain business combinations that could ultimately improve our financial results. We cannot assure you that additional financing will be available on commercially reasonable terms or at all. We currently have no commitments for additional financing.

          Prior to the consummation of the HP Transaction, our capital requirements and level of expenses depended upon numerous factors, including the scope and success of our marketing and customer service efforts, and of our research and development activities, as well as the demand for our products and services. Now that the HP Transaction has been consummated, we have only nominal operations and our cash balance is sufficient for our present requirements.

6



          We have historically funded our operations primarily through the private sale of our equity securities and commercial bank loans. We invest our excess cash in cash, cash equivalents and short term bank deposits that are highly liquid. At June 30, 2008 we had approximately $78.4 million of cash and cash equivalents compared with $8.1 at June 30, 2007.

Operating activities

          In the six months ended June 30, 2008, we had net income of $86.1 million. Net cash used in operating activities was approximately $4.7 million. Most of our assets were sold to HP and the cash generated from the sale is reflected in our net cash provided from investment activities.

          In the six months ended June 30, 2007, we had a net loss of $1.7 million. Net cash used in operating activities was approximately $1.2 million.

          Following the consummation of the HP Transaction, we have ceased conducting any operating activity and substantially all of our assets consist of cash, cash equivalents and short term bank deposits. We now only conduct activities relating to attempting to locate business opportunities and strategic alternatives, activities relating to the investment of our funds and activities relating to the smooth transition of the business acquired by HP. We cannot at this point predict whether following the consummation of a business transaction we will have sufficient working capital in order to fund our operations.

Investing activities

          Net cash provided by investing activities was approximately $100.7 million in the six months ended June 30, 2008, primarily due to proceeds from the HP Transaction.

          Net cash used in investing activities was approximately $0.5 million in the six months ended June 30, 2007.

Financing activities

          Net cash used in financing activities in the six months ended June 30, 2008 was approximately $21.3 million, deriving primarily from repayments of short and long terms loans.

          Net cash provided by financing activities in the six months ended June 30, 2007 was approximately $5 million, deriving primarily from the issuance of shares and warrants in the aggregate net amount of $6.1 million offset by the payment of long-term debt, including interest on restructured debt, in the amount of $0.8 million.

7



          In the beginning of 2007 we raised $6.3 million through the private placement of 11,734,950 of our ordinary shares to various investors at a price of $0.54 per share. The investors also received warrants to purchase additional 3,520,485 ordinary shares at an exercise price of $0.65 per share, exercisable for a period of five years following the closing of the private placement. The private placement included two stages, an initial closing resulting in gross proceeds in the amount of $3.8 million in January 2007 and a follow-on investment resulting in gross proceeds of $2.5 million in February 2007. In connection with the private placement, we paid our adviser, Meitav Underwriting Ltd., a cash fee of $0.25 million.

          Upon consummation of the HP Transaction, we repaid our short-term debt to the Lender Banks in the amount of $9.8 million and, in early April 2008, we fully repaid our long-term debt to the Lender Banks in the amount of $12.1 million. Following the repayment of the loans, two of the three lender banks terminated the floating liens and the securities given by our subsidiaries were terminated. We still have outstanding guarantees which were provided by us to suppliers during the course of our business and which were not yet terminated as a result of the sale of our business to HP. The aggregate value of such guarantees, as of September 15, 2008, is $0.3 million. The guarantees issued by one of the lender banks that terminated the floating liens are secured by liens placed on specific deposits held with such bank, up to the amount of the guarantees.

          Following the repayment of our short and long-term debt to the Lender Banks, as of June 30, 2008 we had no outstanding debt. Our long and short-term credit facilities, excluding accrued interest on restructured debt and a note from a related party, amounted to $ 22 million as of June 30, 2007 and the total usage of our credit lines as of such date was $ 21.7 million.

          As of June 30, 2008, our total current assets amounted to approximately $82.9 million, out of which $78.4 million was in cash and cash equivalents, compared with total current liabilities of approximately $8.4 million.

          As of June 30, 2007, our total current assets amounted to approximately $37.3 million, out of which $8.1 million was in cash and cash equivalents, compared with total current liabilities of approximately $33.3 million.

          The increase in our cash balance and the reduction in our other current assets and liabilities are due to the sale of our business to HP and the cessation of our wide-format printing business at the end of February 2008.

Disclosure about Market Risk

          Following the consummation of the HP Transaction in February 29, 2008, most of our assets are cash, cash equivalents and short term bank deposits, invested mostly in U.S. dollar-denominated deposits with U.S. banks which we carefully monitor with respect to their exposure to the current financial market situation. Other than that, the major market risk is currently the potential decline in the U.S. monetary interest rate that would impact our results of operations.

8



Forward-Looking Statements

          With the exception of historical facts, the matters discussed in this report are forward-looking statements. Forward-looking statements may relate to, among other things, future actions, future performance generally, business development activities, future capital expenditures, strategies, the outcome of contingencies such as legal proceedings, future financial results, financing sources and availability and the effects of regulation and competition. When we use the words “believe,” “intend,” “expect,” “may,” “will,” “should,” “anticipate,” “could,” “estimate,” “plan,” “predict,” “project,” or their negatives, or other similar expressions, the statements which include those words are usually forward-looking statements. When we describe strategy that involves risks or uncertainties or include statements that do not relate strictly to historical or current facts, we are making forward-looking statements.

          Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Please see Item 4.A. “Risk Factors” in our Annual Report on Form 20-F for the year ended December 31, 2007, filed with the SEC on June 30, 2008, in which we have identified important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by us; any such statement is qualified by reference to the following cautionary statements. You should understand that it is not possible to predict or identify all risk factors. Consequently, you should not consider the said section to be a complete discussion of all potential risks or uncertainties. Readers are cautioned not to place undue reliance on these forward-looking statements.

          We warn you that forward-looking statements are only predictions. Actual events or results may differ as a result of risks that we face. Forward-looking statements speak only as of the date they were made and we undertake no obligation to update them.

9



-----END PRIVACY-ENHANCED MESSAGE-----